Get inside Wall Avenue with StreetInsider Premium. Declare your 1-week free trial here.
- Lexaria is making progress with analysis on its DehydraTECH drug supply expertise
- Superior 2nd-generation DehydraTECH 2.0 formulations utilized in ongoing hypertension research
- The corporate intends to monetize its expertise for business use
- Its quest for business success additionally follows its transfer to delist from the Canada Securities Change (“CSE”) to give attention to the Nasdaq itemizing
Lexaria Bioscience (NASDAQ: LEXX) continues to innovate with its DehydraTECH(TM) drug-delivery expertise. It’s always collaborating with analysis establishments and companies to establish different new methods to enhance its expertise. To date, superior DehydraTECH 2.0 formulations are already being utilized by the corporate in ongoing human research. The expertise is already being monetized via business use (https://cnw.fm/jPvBr).
As a part of its quest for progress and success, Lexaria marked its remaining buying and selling day on the Canadian Securities Change (“CSE”) on Wednesday, July 7, 2021 (https://cnw.fm/YDAFp). The transfer noticed the corporate consolidate the buying and selling of its shares solely on the Nasdaq. Because it was listed again in&
NOTE TO INVESTORS: The most recent information and updates regarding LEXX can be found within the firm’s newsroom at https://cnw.fm/LEXX
CBDWire (CBDW) is a specialised data supplier centered on (1) reporting CBD-related information and updates, (2) releasing CBDNewsBreaks crafted to maintain buyers abreast of the most recent and best within the CBD market, (3) refining and enhancing company press releases, (4) delivering end-to-end distribution and social media companies to client-partners and (5) developing efficient company communication options based mostly on the distinctive necessities of CBD corporations. CBDW is completely positioned within the burgeoning CBD sector with a confirmed crew of journalists and researchers working to ship prime quality content material to an expansive audience of buyers, shoppers and trade information retailers. Our dissemination community of over 5,000 downstream distribution factors permits us to ship unparalleled attain, visibility and recognition to corporations working in each cannabidiol and the broader hashish house. CBDWire (CBDW) is the place CBD information, content material and data converge.
To obtain on the spot SMS alerts, textual content CBDWire to 21000 (U.S. Cell Telephones Solely)
For extra data please go to https://www.CBDWire.com
Please see full phrases of use and disclaimers on the CBDWire web site relevant to all content material supplied by CBDW, wherever revealed or re-published: https://CBDWire.com/Disclaimer
Do you’ve gotten questions or are you interested by working with CNW? Ask Our Editor
CBDWire is a part of the InvestorBrandNetwork.